BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Oliva A, Cipolla A, Gizzi F, D'Abramo A, Favaro M, De Angelis M, Ferretti G, Russo G, Iannetta M, Mastroianni CM, Mascellino MT, Vullo V. Severe Bloodstream Infection due to KPC-Producer E coli in a Renal Transplant Recipient Treated With the Double-Carbapenem Regimen and Analysis of In Vitro Synergy Testing: A Case Report. Medicine (Baltimore) 2016;95:e2243. [PMID: 26886594 DOI: 10.1097/MD.0000000000002243] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Li YY, Wang J, Wang R, Cai Y. Double-carbapenem therapy in the treatment of multidrug resistant Gram-negative bacterial infections: a systematic review and meta-analysis. BMC Infect Dis 2020;20:408. [PMID: 32527246 DOI: 10.1186/s12879-020-05133-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Alhashem F, Tiren-Verbeet NL, Alp E, Doganay M. Treatment of sepsis: What is the antibiotic choice in bacteremia due to carbapenem resistant EnterobacteriaceaeWorld J Clin Cases 2017; 5(8): 324-332 [PMID: 28868304 DOI: 10.12998/wjcc.v5.i8.324] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
3 El Nekidy WS, Mooty MY, Attallah N, Cardona L, Bonilla MF, Ghazi IM. Successful treatment of multidrug resistant Klebsiella pneumoniae using dual carbapenem regimen in immunocompromised patient. IDCases 2017;9:53-5. [PMID: 28660131 DOI: 10.1016/j.idcr.2017.06.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
4 Li Q, Cheng Q, Zhao Z, Dai N, Zeng L, Zhu L, Guo W, Li C, Wang J, Li S, Shen N, Ge Q. Novel coronavirus infection and acute kidney injury in two renal transplant recipients: a case report. J Int Med Res 2020;48:300060520964009. [PMID: 33100064 DOI: 10.1177/0300060520964009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
5 Cancelli F, Oliva A, De Angelis M, Mascellino MT, Mastroianni CM, Vullo V. Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study. Biomed Res Int 2018;2018:2785696. [PMID: 30581848 DOI: 10.1155/2018/2785696] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]